Literature DB >> 18090406

Short-term increase in unsafe sexual behaviour after initiation of HAART in Côte d'Ivoire.

Souleymane Diabaté1, Michel Alary, Constance Kanga Koffi.   

Abstract

A study of 312 untreated and 303 HAART-initiating patients to determine whether HAART is related to sexual risk taking in Côte d'Ivoire. At enrollment, unprotected sex was higher among untreated patients (P = 0.014). During follow-up, risk taking was similar (P = 0.484) as a result of an increase in unprotected sex among treated patients (from 20.4 to 30.1%, P < 0.0001) and stability among untreated patients (from 27.0 to 28.8%, P = 0.301). HAART appeared to be associated with sexual risk taking.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18090406     DOI： 10.1097/QAD.0b013e3282f029e8

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  22 in total

Review 1.  Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world.

Authors:  Kartik K Venkatesh; Timothy P Flanigan; Kenneth H Mayer
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

2.  HIV diagnosis and sexual risk behavior intentions among couple VCT clients in Ethiopia.

Authors:  Yung-Ting Bonnenfant; Michelle J Hindin; Duff Gillespie
Journal:  AIDS Care       Date:  2012-03-20

Review 3.  Treatment to prevent transmission of HIV-1.

Authors:  Myron S Cohen; Cynthia L Gay
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

4.  Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers.

Authors:  R Scott McClelland; Susan M Graham; Barbra A Richardson; Norbert Peshu; Linnet N Masese; George H Wanje; Kishorchandra N Mandaliya; Ann E Kurth; Walter Jaoko; Jeckoniah O Ndinya-Achola
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

5.  Association between participant self-report and biological outcomes used to measure sexual risk behavior in human immunodeficiency virus-1-seropositive female sex workers in Mombasa, Kenya.

Authors:  R Scott McClelland; Barbra A Richardson; George H Wanje; Susan M Graham; Esther Mutunga; Norbert Peshu; James N Kiarie; Ann E Kurth; Walter Jaoko
Journal:  Sex Transm Dis       Date:  2011-05       Impact factor: 2.830

6.  Change in sexual activity 12 months after ART initiation among HIV-positive Mozambicans.

Authors:  Cynthia R Pearson; Susan Cassels; Ann E Kurth; Pablo Montoya; Mark A Micek; Stephen S Gloyd
Journal:  AIDS Behav       Date:  2011-05

7.  Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics.

Authors:  Kartik K Venkatesh; Guy de Bruyn; Mark N Lurie; Lerato Mohapi; Paul Pronyk; Mosa Moshabela; Edmore Marinda; Glenda E Gray; Elizabeth W Triche; Neil A Martinson
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

8.  Highly active antiretroviral therapy is associated with decreased incidence of sexually transmitted diseases in a Taiwanese HIV-positive population.

Authors:  Shu-Hsing Cheng; Chin-Hui Yang; Yu-Mei Hsueh
Journal:  AIDS Patient Care STDS       Date:  2013-02-26       Impact factor: 5.078

9.  Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania.

Authors:  M Roura; M Urassa; J Busza; D Mbata; A Wringe; B Zaba
Journal:  Sex Transm Infect       Date:  2008-11-26       Impact factor: 3.519

10.  Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial).

Authors:  Gilbert Ndziessi; Julien Cohen; Charles Kouanfack; Fabienne Marcellin; Maria Patrizia Carrieri; Maria Patrizia Carierri; Gabrièle Laborde-Balen; Camélia Protopopescu; Avelin Fobang Aghokeng; Jean-Paul Moatti; Bruno Spire; Eric Delaporte; Christian Laurent; Sylvie Boyer
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.